glp-1 drugs and addiction Hype Or Hope? Latest Research On Receptor Agonists GLP-1 drugs may help curb

Adverse Effects from GLP-1 Therapeutic Use, Dosing Errors, & Overdose GLP-1 agonists often cause gastrointestinal side effects, occurring in up to 50% of patients in some instances

found that GLP-1 can reduce oxidative stress in BV2 microglia by inhibiting the accumulation of intracellular ROS and release of nitric oxide (NO), as well as by increasing the expression of the antioxidant glutathione peroxidase 1 (GPx1) and superoxide dismutase 1 (SOD1) (184)

Arguably, it is a window of opportunity to extend the healthy life span for women

Additional information Competing interests The authors declare that they have no competing interests that would influence the content of this review

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study